Valuation: genedrive plc

Market Cap 2.09Cr 2.78Cr 2.44Cr 2.27Cr 3.91Cr 265.29Cr 3.98Cr 27Cr 11Cr 131.57Cr 10Cr 10Cr 454.56Cr P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 1.97Cr 2.62Cr 2.3Cr 2.14Cr 3.69Cr 250.27Cr 3.75Cr 25Cr 9.94Cr 124.12Cr 9.83Cr 9.62Cr 428.82Cr EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.5%
Yield 2024 *
-
Yield 2025 -
1 week-2.44%
Current month-23.08%
1 month-23.08%
3 months+9.29%
6 months-6.98%
Current year+14.29%
1 week 0.95
Extreme 0.95
1.1
1 month 0.95
Extreme 0.95
1.38
Current year 0.75
Extreme 0.75
1.5
1 year 0.19
Extreme 0.19
1.5
3 years 0.19
Extreme 0.19
15.38
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 06/08/2024
Director of Finance/CFO 48 07/04/2022
Director TitleAgeSince
Director/Board Member 69 09/04/2018
Director/Board Member 52 22/08/2018
Director/Board Member 56 11/09/2023
Date Insider Type Main position Quantity % Market Cap.
20/12/24 Free 4,00,000 0.0736%
20/12/24 Free 4,00,000 0.0736%
20/12/24 Buy

Chief Financial Officer

10,00,000 0.1841%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.44%-21.57%-92.16% 2.14Cr
-0.07%+0.72%+14.40%-40.61% 1.57TCr
+1.77%+9.36%-0.04%+98.18% 174.45Cr
-0.95%+1.46%-36.11%-80.87% 113.67Cr
+0.44%-2.40%-38.94%+15.08% 98Cr
+0.28%+0.38%-45.34%-54.13% 63Cr
+1.36%+0.15%-47.70%-57.13% 52Cr
+1.37%+3.82%+40.89%-51.71% 47Cr
+1.77%+2.78%-55.63%-60.91% 38Cr
+1.80%+3.52%-17.21%-32.94% 36Cr
Average +0.85%+1.07%-20.72%-35.72% 219.24Cr
Weighted average by Cap. +0.24%+2.41%+3.88%-30.46%

Financials

2024 2025
Net sales 5L 7L 6L 5L 9L 6.37Cr 10L 64.62L 25.29L 3.16Cr 25.02L 24.48L 11Cr 10L 12.69L 11.14L 10.37L 17.88L 12Cr 18.19L 1.23Cr 48.16L 6.01Cr 47.65L 46.62L 21Cr
Net income -70.75L -94.13L -82.6L -76.92L -1.33Cr -90Cr -1.35Cr -9.13Cr -3.57Cr -45Cr -3.53Cr -3.46Cr -154.08Cr -52.31L -69.59L -61.07L -56.87L -98.06L -66Cr -99.74L -6.75Cr -2.64Cr -33Cr -2.61Cr -2.56Cr -113.92Cr
Net Debt -51.69L -68.77L -60.35L -56.2L -96.9L -66Cr -98.56L -6.67Cr -2.61Cr -33Cr -2.58Cr -2.53Cr -112.57Cr -11.82L -15.73L -13.8L -12.85L -22.16L -15Cr -22.54L -1.52Cr -59.68L -7.45Cr -59.04L -57.76L -26Cr
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
29/26/29 GBX 1.000 0.00% 7,34,824
28/26/28 GBX 1.000 -4.76% 68,77,644
27/26/27 GBX 1.050 0.00% 10,07,046
24/26/24 GBX 1.050 0.00% 1,14,889
23/26/23 GBX 1.050 +2.44% 30,35,275

Annual profits - Rate of surprise